Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells
Megan M. Harper(University of Kentucky), Joseph Kim(Beth Israel Deaconess Medical Center)
Cited by 11
Related Papers
Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment
|Gastrointestinal Endoscopy|2018|158
Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
|British Journal of Cancer|2018|56